In conclusion, it has been demonstrated that miRNAs may influence the onset of hypertension by controlling the renin–angiotensin–aldosterone system’s constituent parts, peripheral resistance-inducing processes like inflammation, and modifications to the structural and functional characteristics of vascular smooth muscle and endothelial cells. This evidence concerns the gene REN and hypertensive disorder.